ADMA Biologics, Inc. Reports Second Quarter 2013 Financial and Operational Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported financial and operational results for the quarter ended June 30, 2013. Second quarter highlights include the following:
•ADMA Biologic’s plasma collection facility received German Health Authority (GHA) certification for the sale of source plasma in Europe
Hey, check out all the research scientist jobs. Post your resume today!
ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported financial and operational results for the quarter ended June 30, 2013. Second quarter highlights include the following:
•ADMA Biologic’s plasma collection facility received German Health Authority (GHA) certification for the sale of source plasma in Europe
Hey, check out all the research scientist jobs. Post your resume today!